Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2006

Open Access 01-12-2006 | Research

Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study

Authors: Pilar Carrasco Garrido, Javier de Miguel Díez, Javier Rejas Gutiérrez, Antonio Martín Centeno, Elena Gobartt Vázquez, Ángel Gil de Miguel, Marta García Carballo, Rodrigo Jiménez García

Published in: Health and Quality of Life Outcomes | Issue 1/2006

Login to get access

Abstract

Background

COPD is currently the fourth cause of morbidity and mortality in the developed world. Patients with COPD experience a progressive deterioration and disability, which lead to a worsening in their health-related quality of life (HRQoL). The aim of this work is to assess the Health-Related Quality of Life (HRQoL) of patients with stable COPD followed in primary care and to identify possible predictors of disease.

Methods

It is a multicenter, epidemiological, observational, descriptive study. Subjects of both sexes, older than 40 years and diagnosed of COPD at least 12 months before starting the study were included. Sociodemographic data, severity of disease, comorbidity, and use of health resources in the previous 12 months were collected. All patients were administered a generic quality-of-life questionnaire, the SF-12, that enables to calculate two scores, the physical (PCS-12) and the mental (MCS-12) component summary scores.

Results

10,711 patients were evaluated (75.6% men, 24.4% women), with a mean age of 67.1 years (SD 9.66). The mean value of FEV1 was 35.9 ± 10.0%. Mean PCS-12 and MCS-12 scores were 36.0 ± 9.9 and 48.3 ± 10.9, respectively. Compared to the reference population, patients with COPD had a reduction of PCS-12, even in mild stages of the disease. The correlation with FEV1 was higher for PCS-12 (r = 0.38) than for MCS-12 (r = 0.12). Predictors for both HRQoL components were sex, FEV1, use of oxygen therapy, and number of visits to emergency rooms and hospital admissions. Other independent predictors of PCS-12 were age, body mass index and educational level.

Conclusion

Patients with stable COPD show a reduction of their HRQoL, even in mild stages of the disease. The factors determining the HRQoL include sex, FEV1, use of oxygen therapy, and number of visits to emergency rooms and hospital admissions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pauwels RA, Buist AS, Calverley PMA, Jenkins ChR, Hurd SS, on behalf of the GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global iniciative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001, 163: 1256–1276.PubMedCrossRef Pauwels RA, Buist AS, Calverley PMA, Jenkins ChR, Hurd SS, on behalf of the GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global iniciative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001, 163: 1256–1276.PubMedCrossRef
2.
go back to reference Celli BR, MacNee W, committee members: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23: 932–946.PubMedCrossRef Celli BR, MacNee W, committee members: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23: 932–946.PubMedCrossRef
3.
go back to reference Sobradillo Peña V, Miratvilles M, Gabriel R, Jimenez-Ruiz CA, Villasante C, Masa JF, Viejo JL, Fernández Fau L: Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000, 118: 981–989. 10.1378/chest.118.4.981CrossRef Sobradillo Peña V, Miratvilles M, Gabriel R, Jimenez-Ruiz CA, Villasante C, Masa JF, Viejo JL, Fernández Fau L: Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000, 118: 981–989. 10.1378/chest.118.4.981CrossRef
4.
go back to reference Álvarez Sala JL, Cimas E, Masa JF, Miravitlles M, Molina J, Naberán K, Simonet P, Viejo JL: Recomendaciones para la atención al paciente con enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001, 37: 269–278.PubMedCrossRef Álvarez Sala JL, Cimas E, Masa JF, Miravitlles M, Molina J, Naberán K, Simonet P, Viejo JL: Recomendaciones para la atención al paciente con enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001, 37: 269–278.PubMedCrossRef
6.
go back to reference Mahler D: How should health-related quality of life be assessed in patients with COPD? Chest 2000, 117: 54S-57S. 10.1378/chest.117.2_suppl.54SPubMedCrossRef Mahler D: How should health-related quality of life be assessed in patients with COPD? Chest 2000, 117: 54S-57S. 10.1378/chest.117.2_suppl.54SPubMedCrossRef
7.
go back to reference Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D: Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ 1992, 305: 1145–1148.PubMedCentralPubMedCrossRef Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D: Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ 1992, 305: 1145–1148.PubMedCentralPubMedCrossRef
8.
go back to reference Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30: 473–483.PubMedCrossRef Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30: 473–483.PubMedCrossRef
9.
go back to reference Ware JE, Kosinski M, Keller SD: A 12-item short-form health survey. Construction of scales and preliminary tests of realiabity and validity. Med Care 1996, 34: 220–233. 10.1097/00005650-199603000-00003PubMedCrossRef Ware JE, Kosinski M, Keller SD: A 12-item short-form health survey. Construction of scales and preliminary tests of realiabity and validity. Med Care 1996, 34: 220–233. 10.1097/00005650-199603000-00003PubMedCrossRef
10.
go back to reference Gandek B, Ware J, Aaronson N, Apolone G, Bjorner J, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M: Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: result from the IQUOLA project. J Clin Epidemiolol 1998, 51: 1171–1178. 10.1016/S0895-4356(98)00109-7CrossRef Gandek B, Ware J, Aaronson N, Apolone G, Bjorner J, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M: Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: result from the IQUOLA project. J Clin Epidemiolol 1998, 51: 1171–1178. 10.1016/S0895-4356(98)00109-7CrossRef
11.
go back to reference Doll H, Miravitlles M: Health-Related QOL inAcute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease. A review of the Literature. Pharmacoeconomics 2005,23(4):345–363. 10.2165/00019053-200523040-00005PubMedCrossRef Doll H, Miravitlles M: Health-Related QOL inAcute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease. A review of the Literature. Pharmacoeconomics 2005,23(4):345–363. 10.2165/00019053-200523040-00005PubMedCrossRef
12.
go back to reference Almagro P, Calbo E, de Echagüen AO, et al.: Mortality after hospitalisation for COPD. Chest 2002, 121: 1441–8. 10.1378/chest.121.5.1441PubMedCrossRef Almagro P, Calbo E, de Echagüen AO, et al.: Mortality after hospitalisation for COPD. Chest 2002, 121: 1441–8. 10.1378/chest.121.5.1441PubMedCrossRef
13.
go back to reference Connors AF, Dawson NV, Thomas C, et al.: Outcomesfollowing acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 154: 959–67.PubMedCrossRef Connors AF, Dawson NV, Thomas C, et al.: Outcomesfollowing acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 154: 959–67.PubMedCrossRef
14.
go back to reference García-Aymerich J, Farrero E, Félez MA, et al.: Risk factors of re-admission to hospital for a COPD exacerbation a prospective study. Thorax 2003, 58: 100–5. 10.1136/thorax.58.2.100PubMedCentralPubMedCrossRef García-Aymerich J, Farrero E, Félez MA, et al.: Risk factors of re-admission to hospital for a COPD exacerbation a prospective study. Thorax 2003, 58: 100–5. 10.1136/thorax.58.2.100PubMedCentralPubMedCrossRef
15.
go back to reference Lynn J, Ely W, Zhong Z, et al.: Living and dyingwith chronic pulmonary obstructive disease. J Am Geriatr Soc 2000, 48: S91-S100.PubMedCrossRef Lynn J, Ely W, Zhong Z, et al.: Living and dyingwith chronic pulmonary obstructive disease. J Am Geriatr Soc 2000, 48: S91-S100.PubMedCrossRef
16.
go back to reference Osman LM, Godden DJ, Friend JAR, et al.: Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997, 52: 67–71.PubMedCentralPubMedCrossRef Osman LM, Godden DJ, Friend JAR, et al.: Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997, 52: 67–71.PubMedCentralPubMedCrossRef
17.
go back to reference Barberà JA, Peces-Barba G, Agustí AGN, Izquierdo JL, Monsó E, Montemayor T, Viejo JL, Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR): Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001, 37: 297–316.PubMedCrossRef Barberà JA, Peces-Barba G, Agustí AGN, Izquierdo JL, Monsó E, Montemayor T, Viejo JL, Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR): Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 2001, 37: 297–316.PubMedCrossRef
18.
go back to reference Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987, 106: 196–204.PubMedCrossRef Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987, 106: 196–204.PubMedCrossRef
19.
go back to reference Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J por los investigadores de la Red-IRYSS: El cuestionario de salud SF-36 español: una década de experiencia y nuevos desarrollos. Gaceta Sanitaria, in press. Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J por los investigadores de la Red-IRYSS: El cuestionario de salud SF-36 español: una década de experiencia y nuevos desarrollos. Gaceta Sanitaria, in press.
20.
go back to reference Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L: Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trondelag Health Study (HUNT). J Epidemiol Community Health 2000, 54: 917–922. 10.1136/jech.54.12.917PubMedCentralPubMedCrossRef Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L: Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trondelag Health Study (HUNT). J Epidemiol Community Health 2000, 54: 917–922. 10.1136/jech.54.12.917PubMedCentralPubMedCrossRef
21.
go back to reference Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J: Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a danish longitudinal population study. Eur Respir J 1997, 10: 822–827.PubMed Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J: Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a danish longitudinal population study. Eur Respir J 1997, 10: 822–827.PubMed
22.
go back to reference Ketekaars CAJ, Schlösser MAG, Mostert R, Huyer Abu-Saad H, Halfens RJG, Wouters EFM: Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996, 51: 39–43.CrossRef Ketekaars CAJ, Schlösser MAG, Mostert R, Huyer Abu-Saad H, Halfens RJG, Wouters EFM: Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996, 51: 39–43.CrossRef
23.
go back to reference Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, Plaza V, Prieto L, Anto JM: Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med 1997, 127: 1072–1079.PubMedCrossRef Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, Plaza V, Prieto L, Anto JM: Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med 1997, 127: 1072–1079.PubMedCrossRef
24.
go back to reference Tsukino M, Nishimura K, Ikeda A, Koyama H, Mishima M, Izumi T: Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 1996, 110: 896–903.PubMedCrossRef Tsukino M, Nishimura K, Ikeda A, Koyama H, Mishima M, Izumi T: Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 1996, 110: 896–903.PubMedCrossRef
25.
go back to reference Engström CP, Persson LO, Larsson S, Ryden A, Sullivan M: Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking. A descriptive and comparative study. Thorax 1996, 51: 825–830.PubMedCentralPubMedCrossRef Engström CP, Persson LO, Larsson S, Ryden A, Sullivan M: Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking. A descriptive and comparative study. Thorax 1996, 51: 825–830.PubMedCentralPubMedCrossRef
26.
go back to reference Miravitlles M, Alvarez-Sala JL, Lamarca R, Ferrer M, Masa F, Verea H, Zalacain R, Murio C, Ros F, IMPAC Study Group: Treatment and quality of life in patients with chronic obstructive pulmonary disease. Qual Life Res 2002, 11: 329–338. 10.1023/A:1015520110663PubMedCrossRef Miravitlles M, Alvarez-Sala JL, Lamarca R, Ferrer M, Masa F, Verea H, Zalacain R, Murio C, Ros F, IMPAC Study Group: Treatment and quality of life in patients with chronic obstructive pulmonary disease. Qual Life Res 2002, 11: 329–338. 10.1023/A:1015520110663PubMedCrossRef
27.
go back to reference Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pumonary disease: the ISOLDE trial. BMJ 2000, 320: 1297–1303. 10.1136/bmj.320.7245.1297PubMedCentralPubMedCrossRef Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK: Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pumonary disease: the ISOLDE trial. BMJ 2000, 320: 1297–1303. 10.1136/bmj.320.7245.1297PubMedCentralPubMedCrossRef
28.
go back to reference Spencer S, Calverley PM, Sherwood Burge P, Jones PW: Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163: 122–128.PubMedCrossRef Spencer S, Calverley PM, Sherwood Burge P, Jones PW: Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163: 122–128.PubMedCrossRef
29.
go back to reference De Miguel Díez J, Izquierdo Alonso JL, Rodríguez González-Moro JM, de Lucas Ramos P, Bellón Cano JM, Molina París J: Calidad de vida en la enfermedad pulmonar obstructiva crónica. Influencia del nivel de asistencia de los pacientes. Arch Bronconeumol 2004, 40: 431–437. 10.1157/13066499PubMed De Miguel Díez J, Izquierdo Alonso JL, Rodríguez González-Moro JM, de Lucas Ramos P, Bellón Cano JM, Molina París J: Calidad de vida en la enfermedad pulmonar obstructiva crónica. Influencia del nivel de asistencia de los pacientes. Arch Bronconeumol 2004, 40: 431–437. 10.1157/13066499PubMed
30.
go back to reference Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT: Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med 1995, 151: 61–65.PubMedCrossRef Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT: Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med 1995, 151: 61–65.PubMedCrossRef
31.
go back to reference Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145: 1321–1327.PubMedCrossRef Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145: 1321–1327.PubMedCrossRef
32.
go back to reference Prigatano GP, Wright EC, Levin D: Quality of life and its predictors in patients with chronic obstructive pulmonary disease. Arch Intern Med 1984, 144: 1613–1619. 10.1001/archinte.144.8.1613PubMedCrossRef Prigatano GP, Wright EC, Levin D: Quality of life and its predictors in patients with chronic obstructive pulmonary disease. Arch Intern Med 1984, 144: 1613–1619. 10.1001/archinte.144.8.1613PubMedCrossRef
33.
go back to reference McSweeny J, Grant I, Heaton RK, Adams KM, Timms RM: Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982, 142: 473–478. 10.1001/archinte.142.3.473PubMedCrossRef McSweeny J, Grant I, Heaton RK, Adams KM, Timms RM: Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982, 142: 473–478. 10.1001/archinte.142.3.473PubMedCrossRef
34.
go back to reference Okubadejo AA, Jones PW, Wedzicha JA: Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996, 51: 44–47.PubMedCentralPubMedCrossRef Okubadejo AA, Jones PW, Wedzicha JA: Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996, 51: 44–47.PubMedCentralPubMedCrossRef
35.
go back to reference Ferreira CAS, Stelmach R, Feltrin MIZ, Filho WJ, Chiba T, Cukier A: Evaluation of health-related quality of life in low-income patientes with COPD receiving long-term oxygen therapy. Chest 2003, 123: 136–141. 10.1378/chest.123.1.136CrossRef Ferreira CAS, Stelmach R, Feltrin MIZ, Filho WJ, Chiba T, Cukier A: Evaluation of health-related quality of life in low-income patientes with COPD receiving long-term oxygen therapy. Chest 2003, 123: 136–141. 10.1378/chest.123.1.136CrossRef
36.
go back to reference Wedzicha JA: Effects of long-term oxygen therapy on neuropsychiatric function and quality of life. Respir Care 2000, 45: 119–124.PubMed Wedzicha JA: Effects of long-term oxygen therapy on neuropsychiatric function and quality of life. Respir Care 2000, 45: 119–124.PubMed
37.
go back to reference Okubadejo AA, O'Shea L, Jones PW, Wedzicha JA: Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy. Eur Respir J 1997, 10: 1572–1575. 10.1183/09031936.97.10071572PubMedCrossRef Okubadejo AA, O'Shea L, Jones PW, Wedzicha JA: Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy. Eur Respir J 1997, 10: 1572–1575. 10.1183/09031936.97.10071572PubMedCrossRef
38.
go back to reference Burrows B, Earle RH: Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients. N Engl J Med 1969, 280: 397–404.PubMedCrossRef Burrows B, Earle RH: Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients. N Engl J Med 1969, 280: 397–404.PubMedCrossRef
39.
go back to reference Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries D, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157: 1418–1422.PubMedCrossRef Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries D, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157: 1418–1422.PubMedCrossRef
40.
go back to reference Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R, IMPAC Study Group: Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004, 59: 387–395. 10.1136/thx.2003.008730PubMedCentralPubMedCrossRef Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R, IMPAC Study Group: Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004, 59: 387–395. 10.1136/thx.2003.008730PubMedCentralPubMedCrossRef
41.
go back to reference Fan VS, Curtis JR, Tu S, McDonell MB, Fihn SD: Using quality of life to predict hospitalization and mortality in patients with obstructive lung disease. Chest 2002, 122: 429–436. 10.1378/chest.122.2.429PubMedCrossRef Fan VS, Curtis JR, Tu S, McDonell MB, Fihn SD: Using quality of life to predict hospitalization and mortality in patients with obstructive lung disease. Chest 2002, 122: 429–436. 10.1378/chest.122.2.429PubMedCrossRef
42.
go back to reference Ketekaars CAJ, Schlösser MAG, Mostert R, Huyer Abu-Saad H, Halfens RJG, Wouters EFM: Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996, 51: 39–43.CrossRef Ketekaars CAJ, Schlösser MAG, Mostert R, Huyer Abu-Saad H, Halfens RJG, Wouters EFM: Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996, 51: 39–43.CrossRef
43.
go back to reference De la Iglesia Martínez F, de la Fuente Cid R, Ramos Polledo V, Pellicer Vázquez C, Nicolás Miguel R, Diz-Lois Martínez F: Análisis factorial de la calidad de vida relacionada con la salud de pacientes con enfermedad pulmonar obstructiva crónica estable. Arch Bronconeumol 2001, 37: 410–416.CrossRef De la Iglesia Martínez F, de la Fuente Cid R, Ramos Polledo V, Pellicer Vázquez C, Nicolás Miguel R, Diz-Lois Martínez F: Análisis factorial de la calidad de vida relacionada con la salud de pacientes con enfermedad pulmonar obstructiva crónica estable. Arch Bronconeumol 2001, 37: 410–416.CrossRef
44.
go back to reference Yohannes AM, Roomi J, Waters K, Connolly MJ: Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med 1998, 92: 1231–1236. 10.1016/S0954-6111(98)90426-7PubMedCrossRef Yohannes AM, Roomi J, Waters K, Connolly MJ: Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med 1998, 92: 1231–1236. 10.1016/S0954-6111(98)90426-7PubMedCrossRef
45.
go back to reference Tsukino M, Nishimura K, Ikeda A, Koyama H, Mishima M, Izumi T: Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 1996, 110: 896–903.PubMedCrossRef Tsukino M, Nishimura K, Ikeda A, Koyama H, Mishima M, Izumi T: Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 1996, 110: 896–903.PubMedCrossRef
Metadata
Title
Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study
Authors
Pilar Carrasco Garrido
Javier de Miguel Díez
Javier Rejas Gutiérrez
Antonio Martín Centeno
Elena Gobartt Vázquez
Ángel Gil de Miguel
Marta García Carballo
Rodrigo Jiménez García
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2006
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-4-31

Other articles of this Issue 1/2006

Health and Quality of Life Outcomes 1/2006 Go to the issue